top of page
.png){kind=small}
.png){kind=small}
Active Studies
Sumitomo Pharma Co., Ltd. Study
Study Details: This study is to evaluate bone mineral density with long-term use of the study drug in premenopausal women with heavy menstrual bleeding due to uterine fibroids or moderate-severe pain associated with endometriosis.
Compensation: Up to $2,600.00
Length of Study: Approximately 5 years
You may qualify if you:
-
Are a premenopausal woman 18 to 50 years of age.
-
Are willing to avoid pregnancy for 4 years using nonhormonal methods of contraception.
-
Have a diagnosis of either uterine fibroids with heavy menstrual bleeding or endometriosis with associated moderate to severe pain.
​​
Astellas Hot Flash Study
Study Details: An observational study among women 40-75 years of age with hot flashes associated with menopause.
Subjects will be required to wear a device on their wrist, like a watch, to record hot flashes.
Compensation: Up to $560.00
Length of Study: Approximately 12 months
You may qualify if you:
-
​Are a woman of age between 40-75 years.
-
Have been diagnosed with bothersome hot flashes due to/associated with menopause for at least 3 months.
-
Have been newly prescribed a non-hormone medication for the treatment of hot flashes.
-
Willing to wear a device on your wrist, like a watch, in two-week intervals to record hot flashes.
Bacterial Vaginosis Study
Study Details: The purpose of this study is to assess the safety and tolerability of the study drug.
Compensation: Up to $1302.00
Length of Study: Approximately 130 days
You may qualify if you:
-
Are a woman at least 18 years of age, diagnosed and suffer from recurrent Bacterial Vaginosis and currently have BV.
-
Able to participate in trial as an outpatient, to attend all required visits, and to comply with all trial requirements.
-
Apart from clinical diagnosis of BV, are healthy, in the clinical judgement of the investigator.
-
Able to visit our office 6 times within a specified time frame.
-
Agree to abstain from vaginal intercourse for 21 days.
Endometriosis Study
Study Details: The purpose of this study in to look at the safety and effectiveness of the study drug when taken together with a combination oral contraception.
Compensation: Up to $1600.00
Length of Study: Approximately 1 year
You may qualify if you:
-
Are a premenopausal female 18-49 years of age.​
-
Have a documented diagnosis of endometriosis.
-
Be willing to discontinue use of any prior medications for endometriosis.
-
Meet other testing criteria done in the office at your first visit.
bottom of page